Page last updated: 2024-09-05

tesaglitazar and pregna-4,17-diene-3,16-dione, (17z)-isomer

tesaglitazar has been researched along with pregna-4,17-diene-3,16-dione, (17z)-isomer in 1 studies

Compound Research Comparison

Studies
(tesaglitazar)
Trials
(tesaglitazar)
Recent Studies (post-2010)
(tesaglitazar)
Studies
(pregna-4,17-diene-3,16-dione, (17z)-isomer)
Trials
(pregna-4,17-diene-3,16-dione, (17z)-isomer)
Recent Studies (post-2010) (pregna-4,17-diene-3,16-dione, (17z)-isomer)
7413251508

Protein Interaction Comparison

ProteinTaxonomytesaglitazar (IC50)pregna-4,17-diene-3,16-dione, (17z)-isomer (IC50)
Nuclear receptor subfamily 1 group I member 2Homo sapiens (human)0.0024
Glucocorticoid receptorHomo sapiens (human)6.06
Progesterone receptorHomo sapiens (human)0.74
Mineralocorticoid receptor Homo sapiens (human)1.88
Androgen receptorHomo sapiens (human)0.66
Bile acid receptorHomo sapiens (human)10

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chander, R; Chaturvedi, D; Ray, S; Srivastava, AK1

Other Studies

1 other study(ies) available for tesaglitazar and pregna-4,17-diene-3,16-dione, (17z)-isomer

ArticleYear
Omega-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents.
    Bioorganic & medicinal chemistry, 2008, Mar-01, Volume: 16, Issue:5

    Topics: Alkanes; Alkylation; Amination; Animals; Hypoglycemic Agents; Hypolipidemic Agents; Lipid Metabolism; Male; Molecular Structure; Naphthalenes; PPAR gamma; Rats; Structure-Activity Relationship

2008